Loading
Latest filing published 07 Dec 2010 for ADVANCIS PHARMACEUTICAL CORP, €1,164.
No signal scores available.
Brad Cole appears in our data through filings on Advancis Pharmaceutical Corp shares, published by SEC (Form 4). Between 12 September 2008 and 6 December 2010, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 1 sale worth €1,164. Outside the open market, there are 3 share grants. So far in 2010, the count stands at no purchases and 1 sale.
The newest entry dates from 7 December 2010: an open-market sale of €1,164, in Advancis Pharmaceutical Corp. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations